+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

MilliporeSigma - Strategic SWOT Analysis Review

  • ID: 4382956
  • SWOT Analysis
  • December 2019
  • 44 pages
  • GlobalData

FEATURED COMPANIES

  • Abcam Inc
  • Bio-Rad Laboratories Inc
  • GE Healthcare LLC
  • Life Technologies Corp
  • Wako Chemicals USA, Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

MilliporeSigma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.

MilliporeSigma Key Recent Developments

Nov 25, 2019: Dana-Farber joins with leading Boston teaching hospitals and universities in announcing new center for advanced biological innovation and manufacturing
Nov 25, 2019: Harvard Announces $50M Investment for Cell and Viral Vector Manufacturing Center at Greater Boston Area in Massachusetts, US
Jul 25, 2019: 908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Apr 18, 2019: DyNAbind now offers a fragment-based DEL kit available through MilliporeSigma
Apr 02, 2019: MilliporeSigma elevates its Biocontinuum platform strategy to deliver ‘contiguous’ bioprocessing

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam Inc
  • Bio-Rad Laboratories Inc
  • GE Healthcare LLC
  • Life Technologies Corp
  • Wako Chemicals USA, Inc.
Section 1 - About the Company
  • MilliporeSigma - Key Facts
  • MilliporeSigma - Key Employees
  • MilliporeSigma - Major Products and Services
  • MilliporeSigma - History
  • MilliporeSigma - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • MilliporeSigma - Business Description
  • MilliporeSigma - Strengths
  • MilliporeSigma - Weaknesses
  • MilliporeSigma - Opportunities
  • MilliporeSigma - Threats
  • MilliporeSigma - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • MilliporeSigma, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • MilliporeSigma, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • MilliporeSigma, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Nov 25, 2019: Dana-Farber joins with leading Boston teaching hospitals and universities in announcing new center for advanced biological innovation and manufacturing
  • Nov 25, 2019: Harvard Announces $50M Investment for Cell and Viral Vector Manufacturing Center at Greater Boston Area in Massachusetts, US
  • Jul 25, 2019: 908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
  • Apr 18, 2019: DyNAbind now offers a fragment-based DEL kit available through MilliporeSigma
  • Apr 02, 2019: MilliporeSigma elevates its Biocontinuum platform strategy to deliver ‘contiguous’ bioprocessing
  • Mar 20, 2019: Merck Opens First M Lab Collaboration Center in Europe
  • Mar 04, 2019: MilliporeSigma awarded Canadian CRISPR nickase patent for foundational genome-editing technology
  • Feb 21, 2019: New strategy improves efficiency of CRISPR-Cas9 genome editing
  • Feb 19, 2019: MilliporeSigma receives first U.S. patent for improved CRISPR genome-editing method
  • Dec 17, 2018: MilliporeSigma’s new Steritest NEO devices provide safer, more reliable, and more convenient sterility testing
Section 5 - Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • MilliporeSigma, Key Facts
  • MilliporeSigma, Key Employees
  • MilliporeSigma, Major Products and Services
  • MilliporeSigma, History
  • MilliporeSigma, Subsidiaries
  • MilliporeSigma, Joint Venture
  • MilliporeSigma, Key Competitors
  • MilliporeSigma, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • MilliporeSigma, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • MilliporeSigma, Recent Deals Summary
List of Figures
  • MilliporeSigma, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • MilliporeSigma, Medical Equipment, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Wako Chemicals USA, Inc.
  • Thermo Fisher Scientific Inc
  • Life Technologies Corp
  • GE Healthcare LLC
  • Bio-Rad Laboratories Inc
  • Abcam Inc
Note: Product cover images may vary from those shown
Adroll
adroll